These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6821812)

  • 21. Mitomycin, doxorubicin, and vinblastine as second-line chemotherapy in patients with advanced breast cancer.
    Borovik R; Epelbaum R; Cohen Y; Robinson E
    Cancer Treat Rep; 1986 Apr; 70(4):517-8. PubMed ID: 3698045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitomycin C in metastatic breast cancer resistant to hormone therapy and conventional chemotherapy.
    De Lena M; Jirillo A; Brambilla C; Villa S
    Tumori; 1980 Aug; 66(4):481-87. PubMed ID: 7414712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of hexamethylmelamine alone and in combination with mitomycin C and vincristine in advanced breast carcinoma.
    Legha SS; Buzdar AU; Hortobagyi GN; DiStefano A; Wiseman CL; Yap HY; Blumenschein GR; Bodey GP
    Cancer Treat Rep; 1979; 63(11-12):2053-6. PubMed ID: 118805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.
    Powles TJ; Jones AL; Judson IR; Hardy JR; Ashley SE
    Br J Cancer; 1991 Aug; 64(2):406-10. PubMed ID: 1892775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclophosphamide, methotrexate,5-fluorouracil, alternating with adriamycin and mitomycin C in metastatic breast cancer: a pilot study.
    Cruciani G; Tienghi A; Molinari AL; Fiorentini G; Rosti G; Turci D; Marangolo M
    Tumori; 1987 Jun; 73(3):303-7. PubMed ID: 3111046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.
    Steiner R; Stewart JF; Cantwell BM; Minton MJ; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1553-7. PubMed ID: 6357805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitomycin-C and vinblastine in advanced breast cancer.
    Navarro M; Bellmunt J; Balañá C; Colomer R; Jolis L; del Campo JM
    Oncology; 1989; 46(3):137-42. PubMed ID: 2497417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy induces regression of brain metastases in breast carcinoma.
    Rosner D; Nemoto T; Lane WW
    Cancer; 1986 Aug; 58(4):832-9. PubMed ID: 3755076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed dose short course mitomycin C with vincristine in advanced pre-treated breast cancer.
    Millward MJ; Hendrick A; Cantwell BM
    Ann Oncol; 1990 Sep; 1(5):373-4. PubMed ID: 2124501
    [No Abstract]   [Full Text] [Related]  

  • 30. A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT).
    Chang YC; Falkson G; Tormey DC; Crowley J
    Am J Clin Oncol; 1982 Oct; 5(5):521-5. PubMed ID: 7180830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternating chemotherapy in advanced gastric cancer. A phase II study.
    Feliu J; Girón CG; González-Baron M; Berrocal A; Barón-Saura JM
    Cancer Chemother Pharmacol; 1991; 28(4):313-4. PubMed ID: 1908751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate].
    Yoshimoto J; Ochi J; Tanahashi T; Nanba K; Saegusa M; Hara M; Akagi T; Obama T; Tsushima T; Ozaki Y
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC).
    Rainey JM; Jones SE; Salmon SE
    Cancer; 1979 Jan; 43(1):66-71. PubMed ID: 761176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arterial infusion of combination chemotherapy consisting of adriamycin and mitomycin C for liver metastases of breast cancer].
    Tada A; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Yamazaki H; Nakamura T; Ueno K; Mukaiyama T; Ito Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):70-4. PubMed ID: 3079990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
    Smith FP; Hoth DF; Levin B; Karlin DA; MacDonald JS; Woolley PV; Schein PS
    Cancer; 1980 Nov; 46(9):2014-8. PubMed ID: 7427908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer.
    Taylor CW; Dalton WS; Mosley K; Dorr RT; Salmon SE
    Breast Cancer Res Treat; 1997 Jan; 42(1):7-14. PubMed ID: 9116320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.
    Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL
    Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C.
    Villani F; Comazzi R; Lacaita G; Guindani A; Genitoni V; Volonterio A; Brambilla MC
    Med Oncol Tumor Pharmacother; 1985; 2(2):93-7. PubMed ID: 3932789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.